M. Colnaghi

Most-cited papers

1. A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.

   S. Righetti, G. della Torre, S. Pilotti, S. Ménard +10 more

   1996Cancer Research293 citations

   Semantic Scholar

   Save

2. Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody.

   S. Canevari, G. Stoter, F. Arienti, Giorgio Bolis +14 more

   1995Journal of the National Cancer Institute200 citations

   Semantic Scholar

   Save

3. The 67 kDa laminin receptor as a prognostic factor in human cancer

   S. Ménard, E. Tagliabue, M. Colnaghi

   2004Breast Cancer Research and Treatment157 citations

   Semantic Scholar

   Save

4. Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables.

   S. Ménard, P. Valagussa, S. Pilotti, L. Gianni +8 more

   2001Journal of Clinical Oncology157 citations

   Semantic Scholar

   Save

5. The 67-kDa laminin receptor originated from a ribosomal protein that acquired a dual function during evolution.

   E. Ardini, G. Pesole, E. Tagliabue, Alessandra Magnifico +4 more

   1998Molecular biology and evolution150 citations Open access

   Semantic Scholar

   Save

6. Formation of the 67‐kDa laminin receptor by acylation of the precursor

   S. Butó, E. Tagliabue, E. Ardini, Alessandra Magnifico +6 more

   1998Journal of Cellular Biochemistry131 citations

   Semantic Scholar

   Save

7. Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas.

   S. Ménard, G. Tomasic, P. Casalini, A. Balsari +5 more

   1997Clinical Cancer Research129 citations

   Semantic Scholar

   Save

8. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19.

   L. Mantovani, S. Miotti, S. Ménard, Silvana Canevari +4 more

   1994European Journal of Cancer118 citations

   Semantic Scholar

   Save

9. Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells.

   E. Tagliabue, C. Ghirelli, P. Squicciarini, P. Aiello +2 more

   1998Clinical Cancer Research110 citations

   Semantic Scholar

   Save

10. Co-regulation and Physical Association of the 67-kDa Monomeric Laminin Receptor and the α6β4 Integrin*

    E. Ardini, E. Tagliabue, Alessandra Magnifico, S. Butó +3 more

    1997Journal of Biological Chemistry85 citations Open access

    Semantic Scholar

    Save

11. Panning phage antibody libraries on cells: isolation of human Fab fragments against ovarian carcinoma using guided selection.

    M. Figini, L. Obici, D. Mezzanzanica, Andrew D. Griffiths +3 more

    1998Cancer Research83 citations

    Semantic Scholar

    Save

12. Interaction of folate receptor with signaling molecules lyn and G(alpha)(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1.

    S. Miotti, M. Bagnoli, A. Tomassetti, M. Colnaghi +1 more

    2000Journal of Cell Science78 citations

    Semantic Scholar

    Save

13. Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas.

    S. Pupa, R. Bufalino, A. Invernizzi, S. Andreola +4 more

    1996Journal of Clinical Oncology77 citations

    Semantic Scholar

    Save

14. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.

    L. Coney, Delia Mezzanzanica, D. Sanborn, Patrizia Casalini +2 more

    1994Cancer Research71 citations

    Semantic Scholar

    Save

15. Protection against doxorubicin‐induced alopecia in rats by liposome‐entrapped monoclonal antibodies

    A. Balsari, D. Morelli, S. Ménard, Umberto Veronesi +1 more

    1994The FASEB Journal63 citations

    Semantic Scholar

    Save

16. Transfer of chimeric receptor gene made of variable regions of tumor-specific antibody confers anticarbohydrate specificity on T cells.

    D. Mezzanzanica, S. Canevari, Alessandra Mazzoni, M. Figini +4 more

    1998Cancer Gene Therapy60 citations

    Semantic Scholar

    Save

17. Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation

    C. Giani, Patrizia Casalini, S. Pupa, R. De Vecchi +4 more

    1998Oncogene57 citations Open access

    Semantic Scholar

    Save

18. Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice.

    D. Morelli, S. Ménard, M. Colnaghi, A. Balsari

    1996Cancer Research57 citations

    Semantic Scholar

    Save

19. Laminin receptor expression and function in small‐cell lung carcinoma

    R. Pellegrini, S. Martignone, S. Ménard, M. Colnaghi

    1994International journal of cancer. Supplement = Journal international du cancer. Supplement56 citations

    Semantic Scholar

    Save

20. Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model.

    S. Ménard, P. Aiello, E. Tagliabue, C. Rumio +3 more

    2000Cancer Research54 citations

    Semantic Scholar

    Save

21. Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats.

    R. Cécé, S. Cazzaniga, D. Morelli, Lucia Sfondrini +4 more

    1996Laboratory investigation; a journal of technical methods and pathology54 citations

    Semantic Scholar

    Save

22. Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines

    S. Miotti, M. Bagnoli, F. Ottone, A. Tomassetti +2 more

    1997Journal of Cellular Biochemistry52 citations

    Semantic Scholar

    Save

23. Peptide G, Containing the Binding Site of the 67-kDa Laminin Receptor, Increases and Stabilizes Laminin Binding to Cancer Cells*

    Alessandra Magnifico, E. Tagliabue, S. Butó, E. Ardini +3 more

    1996Journal of Biological Chemistry52 citations Open access

    Semantic Scholar

    Save

24. Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features.

    S. Ménard, Paolo Squicciarini, A. Luini, V. Sacchini +6 more

    1994British Journal of Cancer51 citations Open access

    Semantic Scholar

    Save

25. Bispecific Antibody Targeted T Cell Therapy of Ovarian Cancer: Clinical Results and Future Directions

    S. Canevari, D. Mezzanzanica, Alessandra Mazzoni, Donatella R. M. Negri +4 more

    1995Journal of Hematotherapy50 citations

    Semantic Scholar

    Save

26. Level of anti‐mouse‐antibody response induced by bi‐specific monoclonal antibody OC/TR in ovarian‐carcinoma patients is associated with longer survival

    S. Miotti, Donatella R. M. Negri, O. Valota, M. Calabrese +4 more

    1999International Journal of Cancer49 citations Open access

    Semantic Scholar

    Save

27. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma.

    A. Balsari, J. A. Maier, M. Colnaghi, S. Ménard

    1999Laboratory investigation; a journal of technical methods and pathology49 citations

    Semantic Scholar

    Save

28. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.

    Patrizia Casalini, Elena Luison, S. Ménard, M. Colnaghi +2 more

    1997Journal of Nuclear Medicine48 citations

    Semantic Scholar

    Save

29. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.

    Alessandra Mazzoni, Delia Mezzanzanica, G. Jung, H. Wolf +2 more

    1996Cancer Research48 citations

    Semantic Scholar

    Save

30. Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors

    S. Ménard, P. Casalini, G. Tomasic, S. Pilotti +6 more

    1999Breast Cancer Research and Treatment45 citations

    Semantic Scholar

    Save

31. Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography.

    Pei-Yong Li, S. Del Vecchio, Rosa Fonti, M. Carriero +7 more

    1996Journal of Nuclear Medicine45 citations

    Semantic Scholar

    Save

32. Evaluation of the balance between angiogenic and antiangiogenic circulating factors in patients with breast and gastrointestinal cancers.

    D. Morelli, D. Lazzerini, S. Cazzaniga, Paolo Squicciarini +6 more

    1998Clinical Cancer Research36 citations

    Semantic Scholar

    Save

33. Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle.

    A. Balsari, P. Casalini, E. Tagliabue, M. Greco +8 more

    1999American Journal of Pathology35 citations Open access

    Semantic Scholar

    Save

34. The LFA‐1/ICAM cell adhesion pathway is involved in tumor‐cell lysis mediated by bispecific monoclonal‐antibody‐targeted T lymphocytes

    S. Ferrini, S. Sforzini, A. Cambiaggi, A. Poggi +4 more

    1994International Journal of Cancer33 citations

    Semantic Scholar

    Save

35. Detection of aberrant isotype switch recombination in low-grade and high-grade gastric MALT lymphomas.

    Elena Nardini, Antonella Aiello, R. Giardini, M. Colnaghi +2 more

    2000Blood31 citations

    Semantic Scholar

    Save

36. Growth of ovarian‐carcinoma cell lines at physiological folate concentration: Effect on folate‐binding protein expression in vitro and in vivo

    S. Miotti, P. Facheris, A. Tomassetti, Federica Bottero +6 more

    1995International Journal of Cancer31 citations

    Semantic Scholar

    Save

37. Shedding of the 67‐kD laminin receptor by human cancer cells

    M. Karpatová, E. Tagliabue, V. Castronovo, Alessandra Magnifico +5 more

    1996Journal of Cellular Biochemistry29 citations

    Semantic Scholar

    Save

38. In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.

    Donatella R. M. Negri, E. Tosi, O. Valota, S. Ferrini +6 more

    1995British Journal of Cancer29 citations Open access

    Semantic Scholar

    Save

39. Ectopic expression of pRb2/p130 suppresses the tumorigenicity of the c-erbB-2-overexpressing SKOV3 tumor cell line

    S. Pupa, C. Howard, A. Invernizzi, R. De Vecchi +5 more

    1999Oncogene26 citations

    Semantic Scholar

    Save

40. Anti‐tumor efficacy of an anti‐epidermal‐growth‐factor‐ receptor monoclonal antibody and its F(ab′)2 fragment against high‐ and low‐egfr‐expressing carcinomas in nude mice

    E. Tosi, O. Valota, Donatella R. M. Negri, E. Adobati +5 more

    1995International Journal of Cancer26 citations

    Semantic Scholar

    Save

41. Clavin, a Type‐1 Ribosome‐Inactivating Protein from Aspergillus clavatus IF0 8605

    D. Parente, G. Raucci, B. Celano, A. Pacilli +9 more

    199625 citations

    Semantic Scholar

    Save

42. Immunohistochemical reactivity of a monoclonal antibody prepared against human breast carcinoma

    R. Mariani-Costantini, M. Colnaghi, F. Leoni, S. Ménard +2 more

    2004Virchows Archiv24 citations

    Semantic Scholar

    Save

43. Relationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.

    F. Ottone, S. Miotti, C. Bottini, M. Bagnoli +3 more

    1997British Journal of Cancer24 citations Open access

    Semantic Scholar

    Save

44. Inhibition of tumorigenicity in lung adenocarcinoma cells by c‐erbB‐2 antisense expression

    P. Casalini, S. Ménard, Sergio M. I. Malandrin, Cristina M. Rigo +3 more

    1997International Journal of Cancer22 citations Open access

    Semantic Scholar

    Save

45. Heregulin β1 induces the down regulation and the ubiquitin‐proteasome degradation pathway of p185HER2 oncoprotein

    Alessandra Magnifico, E. Tagliabue, E. Ardini, Patrizia Casalini +2 more

    1998FEBS Letters21 citations Open access

    Semantic Scholar

    Save

46. Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation

    N. Jacobs, A. Mazzoni, D. Mezzanzanica, Donatella Negri +5 more

    1997Cancer Immunology and Immunotherapy20 citations Open access

    Semantic Scholar

    Save

47. No additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomas.

    S. Ménard, Patrizia Casalini, S. Pilotti, N. Cascinelli +2 more

    1996Journal of the National Cancer Institute20 citations Open access

    Semantic Scholar

    Save

48. Antigenic and immunogenic mimicry of the HER2/neu oncoprotein by phage‐displayed peptides

    R. Orlandi, S. Ménard, M. Colnaghi, C. Boyer +1 more

    1994European Journal of Immunology19 citations

    Semantic Scholar

    Save

49. A Linear Region of a Monoclonal Antibody Conformational Epitope Mapped on p185HER2 Oncoprotein

    R. Orlandi, Cristina Formantici, S. Ménard, C. Boyer +2 more

    1997Biological chemistry18 citations

    Semantic Scholar

    Save

50. In vitro mimicry of CaMBr1 tumor-associated antigen by synthetic oligosaccharides.

    Elena Adobati, L. Panza, G. Russo, M. Colnaghi +1 more

    1997Glycobiology17 citations

    Semantic Scholar

    Save